临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

肿瘤靶向药物相关的间质性肺病的研究进展

王慧,宗晓福   

  1. 解放军八一医院呼吸科
  • 收稿日期:2012-11-06 修回日期:2013-02-07 出版日期:2013-04-30 发布日期:2013-04-30
  • 通讯作者: 宗晓福

The advances on interstitial lung disease associated with molecular targeted drugs

WANG Hui, ZONG Xiaofu   

  1. Department of Respiratory Medicine, the 81st Hospital of PLA
  • Received:2012-11-06 Revised:2013-02-07 Online:2013-04-30 Published:2013-04-30
  • Contact: ZONG Xiaofu

摘要: 肿瘤靶向药物有独特的靶向抗肿瘤作用,在当前临床治疗中已发挥重要作用,并显示出良好的应用前景。但随着靶向药物应用范围的不断扩大,与其相关的间质性肺病的报道也越来越多。目前,靶向药物相关间质性肺病的发病机制尚不清楚,也缺乏规范化的诊断治疗指南。立即撤除肿瘤靶向药物、静脉激素的使用及氧疗是目前推荐的治疗方案。

Abstract: Tumor targeted drugs possess distinct effect of targeted antitumor, which have played an important role in recent clinical therapy and displayed satisfactory prospect.With the continuous enlargement of application range of targeted drugs, interstitial lung disease associated with them is reported more and more frequently. The pathogenesis and standardized treatment guidelines of interstitial lung disease associated with targeted drugs remain unknown. Immediate withdrawal of tumor targeted drugs, intravenous corticosteroid hormones and oxygen therapy is current recommended management.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!